Okay thread...finally, watched the vid-- it serves as a nice introduction to the company and a reminder that there are actually people behind these stock symbols.
After I digest their website and go through the annual report maybe I'll have some questions for the thread. I wont be rushing in to buy shares, with Greenspan taking the punchbowl away and all...but this seems like one to follow for sure, maybe buy in the fall or on a dip.
Mr Crook said something like Isis has 95% of the backbone chemistry--and based on the list of companies persuing antisense in that April bionav issue, I was surprised by this--but I suppose it depends on how you define "the chemistry". It is going to take me awhile to formulate an intelligent question regarding 'backbone chemistry', plenty of stuff to read on their website I see, need to do that next.
Finally, I got the impression that Isis needs a genomics partner, a company with a bunch of gene patents but no platform to try out on them, just a thought. If biotech wasn't in a financing depression, they could issue shares, raise some cash, and go out and buy a Curagen or a Gene Logic, does that make sense? Although I have only a rough idea about what Isis needs in the way of genes, it sounds like they need a lot of genes...and they work down to targets, rather than the other way around. (?)
Good luck to all, I'll mainly be lurking, til I have questions that don't look ridiculously simplistic.
--Mike |